CrossrefInfokarte
CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
Cancer Management and Research · 2026-06 · Volume 18 · 1-19
DOI: 10.2147/cmar.s611187 ↗Abstract
Kein Abstract verfügbar.
EUVIMED